Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers

Details for Australian Patent Application No. 2006328950 (hide)

Owner Novartis AG

Inventors Ahlheim, Markus; Petersen, Holger

Agent Davies Collison Cave

Pub. Number AU-B-2006328950

PCT Pub. Number WO2007/071395

Priority 0526247.2 22.12.05 GB; 06119086.4 17.08.06 EP

Filing date 20 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 29 July 2010

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071395 Priority application(s): WO2007/071395

29 July 2010 Application Accepted

  Published as AU-B-2006328950

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328951-Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions

2006328949-Combination of a 5-HT4 agonist with a cholinesterase inhibitor